Literature DB >> 15023857

Multiple actions of anandamide on neonatal rat cultured sensory neurones.

Rhian M Evans1, Roderick H Scott, Ruth A Ross.   

Abstract

1. We have investigated the effects of the endocannabinoid anandamide (AEA) on neuronal excitability and vanilloid TRPV1 receptors in neonatal rat cultured dorsal root ganglion neurones. 2. Using whole-cell patch-clamp electrophysiology, we found that AEA inhibits high-voltage-activated Ca(2+) currents by 33+/-9% (five out of eight neurones) in the absence of the CB(1) receptor antagonist SR141716A (100 nM) and by 32+/-6% (seven out of 10 neurones) in the presence of SR141716A. 3. Fura-2 fluorescence Ca(2+) imaging revealed that AEA produced distinct effects on Ca(2+) transients produced by depolarisation evoked by 30 mM KCl. In a population of neurones of larger somal area (372+/-20 microM(2)), it significantly enhanced Ca(2+) transients (80.26+/-13.12% at 1 microM), an effect that persists after pertussis toxin pretreatment. In a population of neurones of smaller somal area (279+/-18 microM(2)), AEA significantly inhibits Ca(2+) transients (30.75+/-3.54% at 1 microM), an effect that is abolished by PTX pretreatment. 4. Extracellular application of 100 nM AEA failed to evoke TRPV1 receptor inward currents in seven out of eight neurones that responded to capsaicin (1 microM), with a mean inward current of -0.94+/-0.21 nA. In contrast, intracellular application of 100 nM AEA elicited robust inward currents in approximately 62% of neurones, the mean population response was -0.85+/-0.21 nA. When AEA was applied to the intracellular environment with capsazepine (1 microM), the mean population inward current was -0.01+/-0.01 nA. Under control conditions, mean population current fluctuations of -0.09+/-0.05 nA were observed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023857      PMCID: PMC1574891          DOI: 10.1038/sj.bjp.0705723

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  66 in total

1.  The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.

Authors:  L De Petrocellis; T Bisogno; M Maccarrone; J B Davis; A Finazzi-Agro; V Di Marzo
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

Review 2.  Anandamide: some like it hot.

Authors:  V Di Marzo; T Bisogno; L De Petrocellis
Journal:  Trends Pharmacol Sci       Date:  2001-07       Impact factor: 14.819

3.  Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.

Authors:  R A Ross; T M Gibson; H C Brockie; M Leslie; G Pashmi; S J Craib; V Di Marzo; R G Pertwee
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.

Authors:  V Di Marzo; I Lastres-Becker; T Bisogno; L De Petrocellis; A Milone; J B Davis; J J Fernandez-Ruiz
Journal:  Eur J Pharmacol       Date:  2001-05-25       Impact factor: 4.432

5.  Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

Authors:  C S Breivogel; G Griffin; V Di Marzo; B R Martin
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

6.  Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation.

Authors:  M Tognetto; S Amadesi; S Harrison; C Creminon; M Trevisani; M Carreras; M Matera; P Geppetti; A Bianchi
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

7.  The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat.

Authors:  T J Price; G Helesic; D Parghi; K M Hargreaves; C M Flores
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2.

Authors:  Shih-Fang Fan; Stephen Yazulla
Journal:  Vis Neurosci       Date:  2003 Mar-Apr       Impact factor: 3.241

9.  Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.

Authors:  Hiroyuki Watanabe; Joris Vriens; Jean Prenen; Guy Droogmans; Thomas Voets; Bernd Nilius
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

10.  Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder.

Authors:  Selena Harrison; Luciano De Petrocellis; Marcello Trevisani; Francesca Benvenuti; Maurizio Bifulco; Pierangelo Geppetti; Vincenzo Di Marzo
Journal:  Eur J Pharmacol       Date:  2003-08-15       Impact factor: 4.432

View more
  17 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

3.  Anandamide produced by Ca(2+)-insensitive enzymes induces excitation in primary sensory neurons.

Authors:  Angelika Varga; Agnes Jenes; Timothy H Marczylo; Joao Sousa-Valente; Jie Chen; Jonothan Austin; Srikumaran Selvarajah; Fabiana Piscitelli; Anna P Andreou; Anthony H Taylor; Fiona Kyle; Mohammed Yaqoob; Sue Brain; John P M White; Laszlo Csernoch; Vincenzo Di Marzo; Laki Buluwela; Istvan Nagy
Journal:  Pflugers Arch       Date:  2013-10-10       Impact factor: 3.657

4.  Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade.

Authors:  Christian Kuc; Audrey Jenkins; Rukiyah T Van Dross
Journal:  Mol Carcinog       Date:  2011-03-22       Impact factor: 4.784

5.  Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.

Authors:  Mario van der Stelt; Marcello Trevisani; Vittorio Vellani; Luciano De Petrocellis; Aniello Schiano Moriello; Barbara Campi; Peter McNaughton; Piero Geppetti; Vincenzo Di Marzo
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

6.  Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors.

Authors:  S Akerman; H Kaube; P J Goadsby
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

7.  Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons.

Authors:  Z-Y Wang; T McDowell; P Wang; R Alvarez; T Gomez; D E Bjorling
Journal:  Neuroscience       Date:  2014-08-01       Impact factor: 3.590

8.  Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk.

Authors:  R M Evans; R H Scott; R A Ross
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

9.  Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites.

Authors:  R M Evans; K N Wease; C J MacDonald; H A Khairy; R A Ross; R H Scott
Journal:  Br J Pharmacol       Date:  2008-03-31       Impact factor: 8.739

10.  A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain.

Authors:  Iryna A Khasabova; Sergey G Khasabov; Catherine Harding-Rose; Lia G Coicou; Bryan A Seybold; Amy E Lindberg; Christopher D Steevens; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.